William B. Horne, Director at Alzamend Neuro, Inc. (ALZN), bought 5,000 shares at $0.98 ($5K) on 2025-03-20, disclosed to the SEC on 2025-03-20.
Open-market purchase of $5k ALZN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| GPUS | BUY | 2026-09-18 | $18K | — | Filing → |
| GPUS | BUY | 2026-09-08 | $31K | — | Filing → |
| GPUS | BUY | 2026-09-02 | $20K | — | Filing → |